unknown
Stage
About
Hanimune Therapeutics develops consumer food products aimed at preventing and managing food allergies by delivering controlled doses of common allergens to build tolerance; offerings include 'Lil Mixins' for early infant allergen introduction and 'Top9Proteins' formulations with reliable allergen quantities.
Explore Hanimune Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.